Keilmann, Lucia http://orcid.org/0000-0002-0795-1680
Beyer, Susanne
Meister, Sarah
Jegen, Magdalena http://orcid.org/0000-0002-5900-6306
Buschmann, Christina
Schröder, Lennard
Keckstein, Simon http://orcid.org/0000-0002-3333-7393
Jeschke, Udo http://orcid.org/0000-0003-2623-3235
Burges, Alexander
Mahner, Sven
Trillsch, Fabian http://orcid.org/0000-0002-1860-4350
Kost, Bernd
Kolben, Thomas
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 22 June 2022
Accepted: 28 July 2022
First Online: 7 September 2022
Declarations
:
: Sven Mahner: research support, advisory board, honoraria and travel expenses from AbbVie, AstraZeneca, Clovis, Eisai, GlaxoSmithKline, Medac, MSD, Novartis, Olympus, PharmaMar, Pfizer, Roche, Sensor Kinesis, Teva, Tesaro. Fabian Trillsch reports grants and personal fees from AstraZeneca, Clovis, Eisai, Medac, MSD, PharmaMar, Roche, and Tesaro/GSK, outside the submitted work. Thomas Kolben holds stock in Roche, and a relative is employed by Roche. Lucia Keilmann and all the other authors declare no conflict of interest.
: This study was performed in line with the principles of the Declaration of Helsinki. Since only anonymised data was evaluated, no approval by the ethics committee was necessary. As these data were generated as part of the quality assurance process, no additional consents to participate and to publish were obtained.